{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:25:26Z","timestamp":1787239526283,"version":"build-2736575974"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaophthalmol.2020.5720","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T11:44:33Z","timestamp":1608723873000},"page":"174","source":"Crossref","is-referenced-by-count":24,"title":["Estimating Cured Fractions of Uveal Melanoma"],"prefix":"10.1001","volume":"139","author":[{"given":"Arun D.","family":"Singh","sequence":"first","affiliation":[{"name":"Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Radivoyevitch","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi200101r1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.62.6.420","article-title":"Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.","volume":"62","author":"Zimmerman","year":"1978","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"eoi200101r2","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/bjo.2003.029058","article-title":"The Zimmerman-McLean-Foster hypothesis: 25 years later.","volume":"88","author":"Singh","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"eoi200101r3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1001\/jamaophthalmol.2015.0887","article-title":"Long-term risk of melanoma-related mortality for patients with uveal melanoma treated with proton beam therapy.","volume":"133","author":"Lane","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"eoi200101r4","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","article-title":"Very long-term prognosis of patients with malignant uveal melanoma.","volume":"44","author":"Kujala","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi200101r5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/leu.2015.258","article-title":"Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation.","volume":"30","author":"Radivoyevitch","year":"2016","journal-title":"Leukemia"},{"issue":"3","key":"eoi200101r6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000480640","article-title":"Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013).","volume":"4","author":"Aronow","year":"2018","journal-title":"Ocul Oncol Pathol"},{"issue":"4","key":"eoi200101r7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1136\/bjophthalmol-2015-306921","article-title":"Fine-needle aspiration biopsy of uveal melanoma: outcomes and complications.","volume":"100","author":"Singh","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"eoi200101r8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.oret.2019.12.020","article-title":"Gene expression profiling prognostication of posterior uveal melanoma: does size matter?","volume":"4","author":"Binkley","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"eoi200101r9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041039","article-title":"Targeted next-generation sequencing of 117 routine clinical samples provides further insights into the molecular landscape of uveal melanoma.","volume":"12","author":"Thornton","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"5","key":"eoi200101r10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases.","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi200101r11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jamaophthalmol.2014.4755","article-title":"Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.","volume":"133","author":"Riemens","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"282","key":"eoi200101r12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"Journal of the American Statistical Association"},{"issue":"8","key":"eoi200101r15","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1167\/iovs.03-0081","article-title":"Uveal melanoma survival in Sweden from 1960 to 1998.","volume":"44","author":"Bergman","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi200101r16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/aos.2018.96.issue-4","article-title":"Genetic prognostication in uveal melanoma.","volume":"96","author":"Dogrus\u00f6z","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"eoi200101r17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1167\/iovs.16-20212","article-title":"The Prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status.","volume":"58","author":"Dogrus\u00f6z","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi200101r18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","article-title":"Estimating prognosis for survival after treatment of choroidal melanoma.","volume":"30","author":"Damato","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"eoi200101r19","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1167\/iovs.17-22255","article-title":"PRiMeUM: a model for predicting risk of metastasis in uveal melanoma.","volume":"58","author":"Vaquero-Garcia","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi200101r20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ophtha.2010.05.023","article-title":"Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens.","volume":"118","author":"Shields","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi200101r21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"eoi200101r22","first-page":"54","article-title":"An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes.","volume":"105","author":"Augsburger","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"eoi200101r23","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma.","volume":"71","author":"Gamel","year":"1993","journal-title":"Cancer"},{"issue":"10","key":"eoi200101r24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaophthalmol.2018.2986","article-title":"Association of uveal melanoma metastatic rate with stochastic mutation rate and type of mutation.","volume":"136","author":"Szalai","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi200101r25","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression.","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"4","key":"eoi200101r26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ophtha.2018.09.031","article-title":"Understanding uveal melanoma metastasis to the liver: the Zimmerman Effect and the Zimmerman hypothesis.","volume":"126","author":"Grossniklaus","year":"2019","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi200101r27","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13139","article-title":"Major patterns of cancer cure: clinical implications.","volume":"28","author":"Tralongo","year":"2019","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"eoi200101r28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12874-020-00946-8","article-title":"On estimating the time to statistical cure.","volume":"20","author":"Jakobsen","year":"2020","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"eoi200101r29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1755-3768.1982.tb08371.x","article-title":"Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943--1952.","volume":"60","author":"Jensen","year":"1982","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"12","key":"eoi200101r30","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.ophtha.2018.03.047","article-title":"Long-term metastatic risk after biopsy of posterior uveal melanoma.","volume":"125","author":"Bagger","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi200101r31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamaophthalmol.2015.4810","article-title":"Hepatic ultrasonography for surveillance in patients with uveal melanoma.","volume":"134","author":"Choudhary","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"eoi200101r32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1136\/bjo.2008.145805","article-title":"Endoresection for choroidal melanoma: palliative or curative intent?","volume":"92","author":"Singh","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi200101r33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/bjo.2008.137562","article-title":"Endoresection in high posterior choroidal melanomas: long-term outcome.","volume":"92","author":"Garc\u00eda-Arum\u00ed","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"eoi200101r34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","article-title":"Does ocular treatment of uveal melanoma influence survival?","volume":"103","author":"Damato","year":"2010","journal-title":"Br J Cancer"},{"issue":"1","key":"eoi200101r35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/IIO.0000000000000053","article-title":"Uveal melanoma: evidence for efficacy of therapy.","volume":"55","author":"Afshar","year":"2015","journal-title":"Int Ophthalmol Clin"},{"key":"eoi200101r36","doi-asserted-by":"crossref","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"eoi200101r37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000367715","article-title":"Adjuvant therapy of uveal melanoma: current status.","volume":"1","author":"Triozzi","year":"2014","journal-title":"Ocul Oncol Pathol"},{"key":"eoi200101r38","first-page":"147","article-title":"Is observation really appropriate for small choroidal melanomas.","volume":"91","author":"Augsburger","year":"1993","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"eoi200101r39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000472153","article-title":"Prognostication for uveal melanoma: are two tests better than one?","volume":"3","author":"Bellerive","year":"2017","journal-title":"Ocul Oncol Pathol"},{"issue":"2","key":"eoi200101r40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.oret.2018.09.007","article-title":"Variability of bad prognosis in uveal melanoma.","volume":"3","author":"Shao","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"eoi200101r41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma.","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"eoi200101r42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12885-017-3149-0","article-title":"Validation of an NGS mutation detection panel for melanoma.","volume":"17","author":"Reiman","year":"2017","journal-title":"BMC Cancer"},{"issue":"5","key":"eoi200101r43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ophtha.2019.11.009","article-title":"Whole exome sequencing identifies candidate genes associated with hereditary predisposition to uveal melanoma.","volume":"127","author":"Abdel-Rahman","year":"2020","journal-title":"Ophthalmology"},{"key":"eoi200101r44","article-title":"Integrative copy number analysis of uveal melanoma reveals novel candidate genes involved in tumorigenesis including a tumor suppressor role for PHF10\/BAF45a.","author":"Bowcock","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"8","key":"eoi200101r45","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0161-6420(00)00182-2","article-title":"Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.","volume":"107","author":"Eskelin","year":"2000","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi200101r46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0161-6420(00)00607-2","article-title":"Uveal melanoma: implications of tumor doubling time.","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi200101r47","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V: twelve-year mortality rates and prognostic factors: COMS report No. 28.","volume":"124","author":"Collaborative Ocular Melanoma Study Group","year":"2006","journal-title":"Arch Ophthalmol"},{"issue":"13","key":"eoi200101r48","first-page":"3032","article-title":"Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway.","volume":"59","author":"Parrella","year":"1999","journal-title":"Cancer Res"},{"issue":"10","key":"eoi200101r49","first-page":"2578","article-title":"Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.","volume":"63","author":"Tschentscher","year":"2003","journal-title":"Cancer Res"},{"issue":"11","key":"eoi200101r50","doi-asserted-by":"publisher","first-page":"6801","DOI":"10.1167\/iovs.15-16822","article-title":"Inferring an evolutionary tree of uveal melanoma from genomic copy number aberrations.","volume":"56","author":"Singh","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi200101r51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma.","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"issue":"10","key":"eoi200101r53","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/cncr.32802","article-title":"Annual report to the nation on the status of cancer, part I: National cancer statistics.","volume":"126","author":"Henley","year":"2020","journal-title":"Cancer"},{"key":"eoi200101r14","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model New York","author":"Therneau","year":"2000"},{"key":"eoi200101r13","unstructured":"Therneau? T. A Package for Survival Analysis in R. R package version 3.1-12. Accessed November 13, 2020. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"eoi200101r52","unstructured":"SEER_brochure.pdf. Accessed November 16, 2020. https:\/\/seer.cancer.gov\/about\/factsheets\/"},{"key":"eoi200101r54","unstructured":"Howlader? N, Noone? AM, Krapcho? M,  SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD. Published April 15, 2020. Accessed November 16, 2020. https:\/\/seer.cancer.gov\/csr\/1975_2017\/"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2774376\/jamaophthalmology_singh_2020_oi_200101_1613153470.64525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T17:34:57Z","timestamp":1613842497000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2774376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5720","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}